Effect of Er:YAG laser combined with minocycline hydrochloride on inflammatory response in patients with combined endodontal-periodontal lesions

Ying Chang,Wenpeng Yang,Jie Liu,Hongjiang Yang,Ruxi Luo,Qian Xu,Xueling Wang
DOI: https://doi.org/10.62347/PKXN1901
2024-10-15
Abstract:Objective: To evaluate the efficacy of Erbium-doped: yttrium-aluminum garnet (Er:YAG) laser combined with minocycline hydrochloride (Mino-HCL) in treating combined endodontal-periodontal lesions (CEPLs), and to provide a clinical reference for its use. Methods: A total of 114 patients with CEPLs, admitted to Aerospace Center Hospital from October 2021 to October 2023, were retrospectively analyzed. Of these, 53 patients were treated with Er:YAG laser (control group) and 61 patients received Er:YAG laser combined with Mino-HCL (research group). Clinical efficacy and pain severity were compared between the two groups. Measurements included plaque index (PLI), sulcus bleeding index (SBI), probing depth (PD), inflammatory factors, and oxidative stress, with adverse effects recorded. A 6-month follow-up assessed the quality of life and oral health outcomes in both groups. Results: The research group demonstrated superior clinical efficacy, reduced pain, and improved management of inflammatory responses and oxidative stress compared to the control group (all P<0.05). Additionally, the research group had lower SBI, PLI, and PD values post-treatment (all P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Follow-up results indicated better quality of life and oral health in the research group. Conclusion: The combination of Er:YAG laser and Mino-HCL is effective for treating CEPLs.
What problem does this paper attempt to address?